Issued 2026-09-16 at $631.18 · now $631.18 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, CACI has typically landed between $555.86 and $724.05 — a range of −11.9% to +14.7% from the issuance price $631.18.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($631.18) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where CACI has typically landed a month from the 2026-09-16 close of $631.18 — the range is history, not a prediction.
- now $631.18 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $641.62 (+1.7%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $606.27–$676.98
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $555.86–$724.05
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-18 | −40.6% | −40.6% | +1.4% |
| 2020-02-19 | −37.0% | −41.4% | +0.0% |
| 2020-02-21 | −33.8% | −38.4% | +0.0% |
| 3 best | |||
| 2026-07-21 | +50.3% | +0.0% | +54.3% |
| 2026-07-20 | +45.4% | −2.3% | +50.7% |
| 2026-07-14 | +45.1% | −5.9% | +45.1% |
5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-16 | Gordon Susan M. | director | Sale | 264 @ $500.38 | $132K | −9.1% of holding | −7.8% | not yet — horizon still open | 2,641 | Form 4 · filed 2 days after the trade |
| 2026-03-11 | Plunkett Debora A | director | Sale | 220 @ $603.30 | $133K | −8.3% of holding | −12.3% | −9.4% | 2,428 | Form 4 · filed 1 day after the trade |
| 2026-02-10 | Koegel J William JR | officer | Sale | 2,000 @ $615.06 | $1.2M | −7.2% of holding | +1.7% | −3.5% | 25,931 | Form 4 · filed 2 days after the trade |
| 2025-12-10 | JEWS WILLIAM L | director | Sale | 3,000 @ $585.82 | $1.8M | −47.0% of holding | −0.0% | −21.4% | 3,384 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
296 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-30 | DISBROW LISA S | director | Award / grant | 58 | 2,510 | Form 4 |
| 2026-07-30 | DISBROW LISA S | director | Award / grant | 58 | 2,510 | Form 4 |
| 2026-07-13 | SZEWS CHARLES L | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | Sloane Stanton D | director | Option exercise | 85 | 1,112 | Form 4 |
| 2026-07-13 | Sloane Stanton D | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | Nolan Philip O | director | Option exercise | 85 | 2,322 | Form 4 |
| 2026-07-13 | MORRISON SCOTT C | director | Option exercise | 85 | 584 | Form 4 |
| 2026-07-13 | Nolan Philip O | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | Plunkett Debora A | director | Option exercise | 85 | 2,597 | Form 4 |
| 2026-07-13 | Plunkett Debora A | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | DISBROW LISA S | director | Option exercise | 123 | 123 | Form 4 |
| 2026-07-13 | Gordon Susan M. | director | Option exercise | 85 | 2,726 | Form 4 |
| 2026-07-13 | Gordon Susan M. | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | McCarthy Ryan D | director | Option exercise | 85 | 2,322 | Form 4 |
| 2026-07-13 | McCarthy Ryan D | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | DISBROW LISA S | director | Option exercise | 123 | 2,452 | Form 4 |
| 2026-07-13 | DISBROW LISA S | director | Option exercise | 123 | 123 | Form 4 |
| 2026-07-13 | Gordon Susan M. | director | Option exercise | 85 | 2,726 | Form 4 |
| 2026-07-13 | Gordon Susan M. | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | MORRISON SCOTT C | director | Option exercise | 85 | 584 | Form 4 |
| 2026-07-13 | MORRISON SCOTT C | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | McCarthy Ryan D | director | Option exercise | 85 | 2,322 | Form 4 |
| 2026-07-13 | McCarthy Ryan D | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | DISBROW LISA S | director | Option exercise | 123 | 2,452 | Form 4 |
| 2026-07-13 | SZEWS CHARLES L | director | Option exercise | 85 | 584 | Form 4 |
| 2026-07-13 | Nolan Philip O | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | Plunkett Debora A | director | Option exercise | 85 | 2,597 | Form 4 |
| 2026-07-13 | Plunkett Debora A | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | SZEWS CHARLES L | director | Option exercise | 85 | 584 | Form 4 |
| 2026-07-13 | SZEWS CHARLES L | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | Sloane Stanton D | director | Option exercise | 85 | 1,112 | Form 4 |
| 2026-07-13 | Sloane Stanton D | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | MORRISON SCOTT C | director | Option exercise | 85 | 85 | Form 4 |
| 2026-07-13 | Nolan Philip O | director | Option exercise | 85 | 2,322 | Form 4 |
| 2026-06-22 | Young David Anthony | officer | Award / grant | 4,448 | 4,448 | Form 4 |
| 2026-06-22 | Young David Anthony | officer | Award / grant | 4,448 | 4,448 | Form 4 |
| 2026-04-26 | Gray DeEtte | officer | Withheld for tax | 4,512 | 39,485 | Form 4 |
| 2026-04-26 | Gray DeEtte | officer | Option exercise | 10,636 | 43,997 | Form 4 |
| 2026-04-26 | Gray DeEtte | officer | Option exercise | 10,636 | 0 | Form 4 |
| 2026-04-26 | Gray DeEtte | officer | Option exercise | 10,636 | 0 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.